These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3266621)

  • 1. In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.
    Yeldandi V; Strodtman R; Lentino JR
    J Antimicrob Chemother; 1988 Dec; 22(6):873-80. PubMed ID: 3266621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Elwell LP; Wilson HR; Knick VB; Keith BR
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1092-4. PubMed ID: 3488022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureus.
    Scheld WM; Keeley JM; Field MR; Brodeur JP
    J Antimicrob Chemother; 1987 May; 19(5):647-58. PubMed ID: 3497147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro resistance of canine staphylococci to trimethoprim and sulphamethoxazole alone and in combination.
    Hinton M; Marston M; Crisfield J
    J Vet Pharmacol Ther; 1981 Mar; 4(1):33-8. PubMed ID: 6984087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
    Unowsky J; Chandrasekar PH; DeLorenzo W; Levine DP
    Chemotherapy; 1986; 32(6):499-505. PubMed ID: 3492342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Branhamella catarrhalis to sulphamethoxazole and trimethoprim.
    Riley TV; Digiovanni C; Hoyne GF
    J Antimicrob Chemother; 1987 Jan; 19(1):39-43. PubMed ID: 3494008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of emergence of bacterial resistance with the combination of sulphamethoxazole and trimethoprim.
    Grüneberg RN; Emmerson AM
    Eur J Clin Microbiol; 1982 Jun; 1(3):155-8. PubMed ID: 6756907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of Staphylococcus aureus to sulphamethoxazole and trimethoprim.
    Nakhla LS
    J Clin Pathol; 1972 Aug; 25(8):708-12. PubMed ID: 5076806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall.
    Goodhart GL
    JAMA; 1984 Nov; 252(19):2748-9. PubMed ID: 6333522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New applications of old antimicrobials.
    Marks MI
    Pediatr Ann; 1986 Jun; 15(6):434-5, 438-40. PubMed ID: 3523401
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trial of ampicillin v. trimethoprim-sulphamethoxazole in the treatment of Shigella dysentery.
    Yunus M; Mizanur Rahman AS; Farooque AS; Glass RI
    J Trop Med Hyg; 1982 Oct; 85(5):195-9. PubMed ID: 6757458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attempts to eradicate methicillin-resistant Staphylococcus aureus colonization with the use of trimethoprim-sulfamethoxazole, rifampin, and bacitracin.
    Roccaforte JS; Bittner MJ; Stumpf CA; Preheim LC
    Am J Infect Control; 1988 Aug; 16(4):141-6. PubMed ID: 3263821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening method for trimethoprim/sulfamethoxazole-resistant small colony variants of Staphylococcus aureus.
    Sato T; Kawamura M; Furukawa E; Fujimura S
    J Glob Antimicrob Resist; 2018 Dec; 15():1-5. PubMed ID: 29857058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim-sulfamethoxazole for bacterial meningitis.
    Levitz RE; Quintiliani R
    Ann Intern Med; 1984 Jun; 100(6):881-90. PubMed ID: 6372565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of antimicrobial agents on macrophage-associated Staphylococcus aureus.
    Nesthus I; Haneberg B; Glette J; Solberg CO
    Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):189-94. PubMed ID: 3875966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 17. Microbiological perspectives of co-trimoxazole.
    Bauernfeind A; Hörl G; Przyklenk B
    Infection; 1987; 15 Suppl 5():S232-5. PubMed ID: 3325434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.
    Sattler FR; Remington JS
    Eur J Clin Microbiol; 1984 Jun; 3(3):174-6. PubMed ID: 6332015
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure of rapid agglutination methods to detect oxacillin-resistant Staphylococcus aureus.
    Ruane PJ; Morgan MA; Citron DM; Mulligan ME
    J Clin Microbiol; 1986 Sep; 24(3):490-2. PubMed ID: 3489732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
    Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
    J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.